Contract Services Clinical Research

Merck Expands Newest Biologics Testing Center in Shanghai

Further develops its biosafety testing laboratories to meet local demand New labs complete 2nd phase of company’s € 29 million...

 November 30, 2023 | News

AbbVie Provides FDA and EMA Updates on Epcoritamab for Lymphoma Treatment

Updates are supported by data from the Phase 1/2 EPCORE™ NHL-1 clinical trial AbbVie  announced updates from the U...

 November 29, 2023 | News

GE HealthCare Releases MyBreastAI Suite to Support Clinicians in Accelerating Breast Cancer Detection

GE HealthCare (Nasdaq: GEHC) announced the release of a new, all-in-one platform of artificial intelligence (AI) apps to support clinicians with breast can...

 November 28, 2023 | News

XtalPi and HKU's Biomedical Instrumentation Centre Partner to Boost Deep Tech Commercialization

XtalPi, a leading global technology company, is renowned for its expertise in integrating physics-based computation, artificial intelligence (AI), and robo...

 November 28, 2023 | News

PharmAbcine Reveals PMC-403 Potential in Idiopathic Systemic Capillary Leak Syndrome Models

The results underscore the novel mechanism of action, demonstrating the ability of PMC-403 to reduce vascular leakage associated with ISCLS in the preclini...

 November 23, 2023 | News

Senhwa Biosciences Granted FDA IND for Phase II Study of Silmitasertib in Viral Community-Acquired Pneumonia (CAP)

The trial is a phase II multi-center, randomized-controlled interventional prospective study, and the purpose of this trial is to investigate whether ...

 November 22, 2023 | News

Metabolon and Trajan Partner for Advanced Metabolomics Microsampling

Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, and Trajan Scientific and Medical...

 November 21, 2023 | News

Taiwan Lubricate for academic research and health products development

In the collaboration with Lipotype GmbH, Germany (the world leader in lipidomics profiling service), T-BAL has developed advanced multi-omics (ma...

 November 20, 2023 | News

ACROBiosystems Introduces GM-Grade DLL4 Protein for Faster Stem Cell Manufacturing

The availability of DLL4 manufactured under GMP conditions represents a significant milestone for enterprises engaged in developing or manufacturing stem-c...

 November 17, 2023 | News

Groundbreaking milestone as the United Kingdom MHRA greenlights CASGEVY™, heralding a new era in CRISPR-based gene editing therapies

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) have shattered scientific barriers today as the United Kingdom Me...

 November 17, 2023 | News

Kite Expands Collaboration with Arcellx, Exercises Option for ACLX-001 in Multiple Myeloma

-- The companies expand the scope of their existing collaboration for CART-ddBCMA to include lymphomas -- -- Kite exercises option to Arcellx’s ARC-...

 November 16, 2023 | News

SCG Cell Therapy's SCG101 Shows Promising Results in First-in-Human Trial for Advanced HBV-related Hepatocellular Carcinoma at AASLD Liver Meeting 2023

Results from a first-in-human clinical trial showed that SCG101 demonstrated promising antiviral and antitumor activities in patients with advanced HBV-rel...

 November 14, 2023 | News

Cromatic closes $5.3 million in oversubscribed seed round to modernize life science R&D outsourcing

 Cromatic, a full-stack digital platform for outsourced life sciences research,  announced it has closed $5.3 million in funding. LifeX Ventures ...

 November 10, 2023 | News

Tempus Collaborates with Bristol Myers Squibb on Multimodal AI Research

"We are looking forward to expanding our relationship with Bristol Myers Squibb and furthering our shared commitment to advancing cancer research and treat...

 November 09, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in